AIRLINK 74.00 Decreased By ▼ -0.25 (-0.34%)
BOP 5.14 Increased By ▲ 0.09 (1.78%)
CNERGY 4.55 Increased By ▲ 0.13 (2.94%)
DFML 37.15 Increased By ▲ 1.31 (3.66%)
DGKC 89.90 Increased By ▲ 1.90 (2.16%)
FCCL 22.40 Increased By ▲ 0.20 (0.9%)
FFBL 33.03 Increased By ▲ 0.31 (0.95%)
FFL 9.75 Decreased By ▼ -0.04 (-0.41%)
GGL 10.75 Decreased By ▼ -0.05 (-0.46%)
HBL 115.50 Decreased By ▼ -0.40 (-0.35%)
HUBC 137.10 Increased By ▲ 1.26 (0.93%)
HUMNL 9.95 Increased By ▲ 0.11 (1.12%)
KEL 4.60 Decreased By ▼ -0.01 (-0.22%)
KOSM 4.83 Increased By ▲ 0.17 (3.65%)
MLCF 39.75 Decreased By ▼ -0.13 (-0.33%)
OGDC 138.20 Increased By ▲ 0.30 (0.22%)
PAEL 27.00 Increased By ▲ 0.57 (2.16%)
PIAA 24.24 Decreased By ▼ -2.04 (-7.76%)
PIBTL 6.74 Decreased By ▼ -0.02 (-0.3%)
PPL 123.62 Increased By ▲ 0.72 (0.59%)
PRL 27.40 Increased By ▲ 0.71 (2.66%)
PTC 13.90 Decreased By ▼ -0.10 (-0.71%)
SEARL 61.75 Increased By ▲ 3.05 (5.2%)
SNGP 70.15 Decreased By ▼ -0.25 (-0.36%)
SSGC 10.52 Increased By ▲ 0.16 (1.54%)
TELE 8.57 Increased By ▲ 0.01 (0.12%)
TPLP 11.10 Decreased By ▼ -0.28 (-2.46%)
TRG 64.02 Decreased By ▼ -0.21 (-0.33%)
UNITY 26.76 Increased By ▲ 0.71 (2.73%)
WTL 1.38 No Change ▼ 0.00 (0%)
BR100 7,874 Increased By 36.2 (0.46%)
BR30 25,599 Increased By 139.8 (0.55%)
KSE100 75,342 Increased By 411.7 (0.55%)
KSE30 24,214 Increased By 68.6 (0.28%)
World

World reaction to Russia's COVID-19 vaccine

  • Moscow said on Wednesday that the first batch of the vaccine would be ready for some medics within two weeks and rejected safety concerns as "groundless".
Published August 12, 2020

Russia's granting of regulatory approval to a COVID-19 vaccine after less than two months of human testing has prompted expressions of caution as well as interest from around the world.

Moscow said on Wednesday that the first batch of the vaccine would be ready for some medics within two weeks and rejected safety concerns as "groundless".

Here is a summary of the reaction:

INQUIRIES

Israel will examine Russia's COVID-19 vaccine and enter negotiations to buy it if it is found to be a "serious product", Israel's health minister said.

Philippine scientists were set to meet representatives of the Russian research facility that developed the vaccine on Wednesday, to discuss possible participation in clinical trials and access to its research data.

Brazil's Parana state governor Ratinho Junior was expected to meet the Russian ambassador to Brazil on Wednesday to discuss the terms of an agreement to produce the vaccine.

But it was unclear if the state's research institute would get regulatory approval in Brazil.

Kazakhstan plans to send government officials to Moscow later this month to discuss possible deliveries.

CAUTION

The World Health Organization and Russian health authorities are discussing the process for possible WHO prequalification, a WHO spokesman said on Tuesday.

"Prequalification of any vaccine includes the rigorous review and assessment of all required safety and efficacy data," WHO spokesman Tarik Jasarevic told a UN briefing in Geneva, referring to clinical trials.

Jarbas Barbosa, assistant director of the WHO's regional branch, the Pan American Health Organization, was asked on Tuesday about potential production of the vaccine in Brazil.

He said that should not be done until Phase 2 and 3 trials are completed to guarantee its safety and effectiveness.

European health experts said that with no full trial data, the vaccine would be hard to trust.

German Health Minister Jens Spahn said the vaccine had not been sufficiently tested, adding the aim was to have a safe product rather than just being first to start vaccinating people.

Mexico's coronavirus czar, Deputy Health Minister Hugo Lopez-Gatell, said he was surprised by the Russian announcement and the government would wait for more information.

Comments

Comments are closed.